Perkins researchers discover muscle disease gene
By Richard Schoonraad | Genes, Genetic Disease, Genetic Disease, Genetic Neuromuscular Disorders, Genetics, News & Events, ResearchResearchers at the Harry Perkins Institute of Medical Research and The University of Western Australia (UWA) have discovered the genetic cause of a rare muscle disease that causes muscle weakness,…
Perkins Represented in Premiers Science Awards
By Richard Schoonraad | Antibiotic diagnostics, awards, BioDiscovery, Community, Epigenetics and Genomics Laboratory, Genetic Disease, Genetic Disease, Lungs, Media Releases, News & Events, ResearchThree celebrated scientists from WA’s Harry Perkins Institute of Medical Research, have been named as finalists in the 2024 Premier’s Science Awards. Associate Professor Gina Ravenscroft, Dr Kieran Mulroney and…
Buckle up as WA’s Premier Truck Show announces HUGE money raised for Cancer Research!
By Richard Schoonraad | Cancer, Community Events, Events, Funding, Fundraising, Media Releases, News & Events, Supporters$500,000 donated to the Harry Perkins Institute of Medical Research in Perth to drive cutting-edge cancer research! Last night the WA Mack Muster and Truck Show team and their sponsors…
1000 walkers raise over $1.45m for women’s cancer research
By Richard Schoonraad | Breast Cancer, Breast Cancer, Cancer, Cancer, Disease Area, Events, Fundraising, News & Events, Ovarian CancerTaking steps to reduce the devastating impact of cancer on women. Fast Facts On average 69,000 new cases of cancer are diagnosed in Australian women each year. One in two…
“Google map” of ovarian tumours reveals cancer cells control who gets into their neighbourhood
By Richard Schoonraad | Cancer, Cancer, Cancer and Cell Biology, Genetic Disease, Genetic Disease, Genome Biology and Genetic Diseases, Lab, News & Events, Ovarian Cancer, Research, TumoursPerth researchers find some ovarian cancer cells appear to tell immune system to stay away. “Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones” published in…
Phase 3 drug trial for rare chronic kidney disease achieves key milestone
By Richard Schoonraad | Chronic Kidney Disease, Kidney Disease, Lab, Media Releases, Molecular Endocrinology and Pharmacology, News & Events, Research, Research AreaBiopharmaceutical company, Dimerix Limited (ASX: DXB, “Dimerix”), which is developing new treatments for types of inflammatory kidney and respiratory diseases, has announced successful interim results of a Phase 3 trial…
Support needed for doctors offering couples genetic testing
By Richard Schoonraad | Epigenetics and Genomics Laboratory, Genetic Disease, Media Releases, Muscles, News & Events, Rare Disease Genetics and Functional Genomics, ResearchAs the number of genetic abnormalities that can be identified in pre and post pregnancy tests reaches the thousands, a national project has been launched to assist doctors as they…
Predicting immunotherapy effectiveness in late-stage liver cancer
By Richard Schoonraad | Cancer, Cancer, Funding, Immunotherapy, Liver, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, ResearchBlood test could hold key to identifying who will respond to immunotherapy after researchers discover biomarkers in liver cancer tissue. Liver cancer researchers at the Harry Perkins Institute of Medical…